10X genomics, INC.:1279204 [23-000660]

Ended Awarded Last action

Contract number
75N92E23F00001
Awardee
Awarding agency
Obligated
$11,449

Award facts

Contract value 100% obligated
$11,448.65 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Pleasanton, CA 94588, USA

Award details come from SAM.gov/FPDS.

About this award

The National Human Genome Research Institute issued a BPA call to 10X Genomics, Inc. with a ceiling value of $11,448.65, awarded November 2, 2022, with an ultimate completion date of November 30, 2023.

Place of performance is Pleasanton, California. The call is firm fixed price with no set-aside. Specific deliverables are not detailed in the source material.

Quick answers

Who was awarded contract 75N92E23F00001?

75N92E23F00001 was awarded to 10X Genomics, Inc. by National Human Genome Research Institute (National Institutes of Health) on November 2, 2022.

How much is contract 75N92E23F00001 worth?

The government has obligated $11,449 on 75N92E23F00001.

Is contract 75N92E23F00001 an order under another contract?

Yes. 75N92E23F00001 is a BPA call under 75N98022A00032, a blanket purchase agreement.

Was contract 75N92E23F00001 competed?

The extent of competition for 75N92E23F00001 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award